The Evaluation of effectiveness of betadine (Povidone-iodine) in one step and two step procedure in the treatment of patients with pleural effusion resistant to conventional treatments: a clinical trial
Phase 1
Recruiting
- Conditions
- Resistant pleural effusion.
- Registration Number
- IRCT20220117053750N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
In this study, patients with refractory pleural effusion with adhesions and a history of VATS and thoracoscopy are eligible for the study.
Exclusion Criteria
In contrast, patients who have a mass for whom catheterization is not possible will be excluded from the study process
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pleural effusion, reduction of pleural effusion. Timepoint: monthly. Method of measurement: Ultrasound of the pleural space.
- Secondary Outcome Measures
Name Time Method Reduce dyspnea and cough. Timepoint: One week after pleural effusion injection. Method of measurement: In this study, a data collection form (Checklist) will be used to collect data. This form consists of 4 main parts. In the first part, the demographic characteristics of patients, including age and sex, as well as the type of pleural effusion disease, which is benign and malignant, are recorded. In the second part, the form of thyroid and kidney enzymes are recorded before and after the intervention. In the third part of the form, the length of the follow-up period and the final outcome of the treatment, which includes the success of the treatment and the failure of the treatment, are recorded. Side effects and patient complaints including chest pain, fever, shortness of breath, hypotension, vision loss, and air leakage are recorded at the end of the form.